AI Verdict
MELI has stronger fundamentals based on our AI analysis.
MELI vs MEDP Fundamental Comparison
| Metric | MELI | MEDP |
|---|---|---|
| Revenue | $28.9B | $2.5B |
| Net Income | $2.0B | $451.1M |
| Net Margin | 6.9% | 17.8% |
| ROE | 29.6% | 98.3% |
| ROA | 4.7% | 22.8% |
| Current Ratio | 1.17x | 0.74x |
| Debt/Equity | 1.36x | 0.00x |
| EPS | $39.40 | $15.28 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MELI vs MEDP: Frequently Asked Questions
Is MELI or MEDP a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MELI has stronger fundamentals. MELI is rated STRONG BUY (92% confidence) while MEDP is rated STRONG BUY (87% confidence). This is not investment advice.
How does MELI compare to MEDP fundamentally?
MERCADOLIBRE INC has ROE of 29.6% vs Medpace Holdings, Inc.'s 98.3%. Net margins are 6.9% vs 17.8% respectively.
Which stock pays higher dividends, MELI or MEDP?
MELI has a dividend yield of N/A or no dividend while MEDP has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MELI or MEDP for long term?
For long-term investing, consider that MELI has STRONG BUY rating with 92% confidence, while MEDP has STRONG BUY rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MELI vs MEDP?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MELI vs MEDP, the AI consensus favors MELI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.